ALBRECHT DETLEF (Chief Medical Officer) sold 3.8% of their position (800.00 shares) of SATSUMA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $16.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/16/2020ACC: 0001567619-20-008036
Officer· Chief Medical Officer
Since Sep 2019
-800.00
Net shares
Net seller
$16.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
800.00 acquired · 1.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+800.00
Price / share
$4.56
Trade value
$3.65K
% of position
4.0%
4/14/2020
20.01K→20.81K
Common Stock
Direct
Shares
−800.00
Price / share
$20.00
Trade value
$16K
% of position
3.8%
4/14/2020
20.81K→20.01K
Total
Net shares
+0.00
Net value
-$12.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/14/2020 | M · Option Exercise | +800.00 | $4.56 | $3.65K | 4.0% | 20.01K | 20.81K |
| Common Stock Direct | 4/14/2020 | S · Sale | −800.00 | $20.00 | $16K | 3.8% | 20.81K | 20.01K |
| Total | +0.00 | -$12.35K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
800.00 shares
Shares
−800.00
Strike price
4.56
Held after
72.47K
Exercisable
—
4/14/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock800.00 shares | 4/14/2020 | S · Sale | −800.00 | 4.56 | — | 72.47K |